On January 18, 2024, our CEO, Ryu Ogawa, will be presenting at the online public seminar “AI in Drug Discovery: Before and After,” hosted by Kanagawa Prefecture, City of Yokohama, and Kawasaki City. This seminar is a part of the Keihin Waterfront Life Innovation International Strategic Comprehensive Special Zone initiatives, promoted by these local governments. Ogawa will introduce our company under the title “Antibody/Peptide Molecular Design Using AI: Introducing Case Studies of Joint Drug Discovery Projects with Pharmaceutical Firms.”

This online seminar will be conducted in Japanese and is open to all without charge. For further information and registration, please visit the official seminar webpage. We look forward to your participation.